Filing Flows › Guardian Pharmacy Services (GRDN) › Guidance & outlook

Guardian Pharmacy Services (GRDN) guidance and outlook

Guardian Pharmacy Services' 10-Q filed Nov 5, 2026 makes 2 forward-looking statements.

Guidance and outlook

2 statements; tone -0.50 (−1 all cautious, +1 all confident); 0 hedged.

Forward-looking statements, 10-Q filed Nov 5, 2026

We expect IRA-related price reductions to continue impacting year-over-year comparability throughout the remainder of 2026.
Revenue recognized reflects the consideration we expect to receive in exchange for these goods and services.

Guardian Pharmacy Services' latest quarter

Guardian Pharmacy Services, Q3 2026: revenue $371M (-2% year over year), operating margin 6.8%, net earnings $18.7M, operating cash flow $43.4M. The chart follows the revenue to costs, profit and cash.

Questions

What does Guardian Pharmacy Services expect?

We expect IRA-related price reductions to continue impacting year-over-year comparability throughout the remainder of 2026. Revenue recognized reflects the consideration we expect to receive in exchange for these goods and services.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.